Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
TA875: Semaglutide for managing overweight and obesity
The estrogen/GLP-1 coagonist loses its potency of action when administered to animals with a CNS specific deletion of the GLP-1R indicating that the GLP-1R is essential for full effectiveness
By purchasing, you confirm you are a qualified researcher or research institution and accept full responsibility for safe and legal handling in accordance with applicable laws
Our compounded semaglutide options, priced at $189/mo, enable transparent cost planning with your HSA
Legal Disclaimer: This product is sold as a research compound only
US$ 25.03
US$ 24.20
US$ 20.87
US$ 26.96
